山东大学学报(医学版) ›› 2015, Vol. 53 ›› Issue (6): 1-6.doi: 10.6040/j.issn.1671-7554.0.2015.001
• 基础医学 • 下一篇
白金霞1, 白金运2, 石秀菊1, 许洪伟1
BAI Jinxia1, BAI Jinyun2, SHI Xiuju1, XU Hongwei1
摘要: 目的 探讨外源性重组小鼠白细胞介素22(rIL-22)对左旋精氨酸诱导的小鼠急性重症胰腺炎(SAP)的保护作用及其介导的信号通路。方法 60只雄性Balb/c小鼠随机分为正常对照组(NaCl组,10只)、SAP组(30只)、治疗对照组(PBS组,10只)和治疗组(rIL-22组,10只)。以8%左旋精氨酸(4 g/kg体质量,腹腔注射2次)诱导小鼠SAP模型,NaCl组注射等量0.9%NaCl。PBS组和rIL-22组分别应用PBS或rIL-22(200 ng/次×5次)在相应时间点进行腹腔注射。光镜下观察胰腺组织病理学改变,检测血清淀粉酶活性。Real-time PCR法检测胰腺组织中IL-22RA1、胰腺再生源蛋白3β(Reg3β)和Reg3γ、B细胞淋巴瘤/白血病-2(Bcl-2)和Bcl-xL基因在mRNA水平的表达。Western blotting方法检测胰腺组织总STAT3和磷酸化STAT3蛋白的表达。对PBS组和rIL-22组的死亡率进行统计。结果 SAP组72 h胰腺组织出现典型的SAP病理改变;随时间延长,SAP组Reg3β和Reg3γ、Bcl-2和Bcl-xL mRNA的表达水平呈递减趋势,血清淀粉酶活性和IL-22RA1 mRNA表达水平先上升后下降。与PBS组相比,rIL-22组血清淀粉酶明显降低(P<0.05),胰腺病理损伤减轻,死亡率下降(P<0.05),胰腺组织磷酸化STAT3表达增加(P<0.05),Reg3β、Reg3γ、Bcl-2、Bcl-xL和IL-22RA1 mRNA的表达上调(P<0.05)。结论 外源性重组IL-22通过激活STAT3信号通路,活化下游抗菌肽和抗凋亡基因的表达,对左旋精氨酸诱导的SAP小鼠起保护作用。
中图分类号:
[1] Rendon JL, Li X, Akhtar S, et al. Interleukin-22 modulates gut epithelial and immune barrier functions following acute alcohol exposure and burn injury[J]. Shock, 2013, 39(1):11-18. [2] Chestovich PJ, Uchida Y, Chang W, et al. Interleukin-22: implications for liver ischemia-reperfusion injury[J]. Transplantation, 2012, 93(5):485-492. [3] Choi SM, McAleer JP, Zheng M, et al. Innate Stat3-mediated induction of the antimicrobial protein Reg3gamma is required for host defense against MRSA pneumonia[J]. J Exp Med, 2013, 210(3):551-561. [4] 杨学超,杨松巍,杨光,等.白细胞介素-22对缺氧条件下肠上皮屏障的保护作用及其机制[J].中华实验外科杂志,2013,30(3):476-479. YANG Xuechao, YANG Songwei, YANG Guang, et al. Preventive effect of interleukin-22 on epithelial barrier function of T84 cells under hypoxia and possible mechanism[J]. Chin J Exp Surg, 2013, 30(3):476-479. [5] Dawra R, Sharif R, Phillips P, et al. Development of a new mouse model of acute pancreatitis induced by administration of L-arginine[J]. Am J Physiol Gastrointest Liver Physiol, 2007, 292(4):G1009-1018. [6] Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method[J]. Methods, 2001, 25(4):402-408. [7] Dumoutier L, Lejeune D, Colau D, et al. Cloning and characterization of IL-22 binding protein, a natural antagonist of IL-10-related T cell-derived inducible factor/IL-22[J]. J Immunol, 2001, 166(12):7090-7095. [8] Ouyang W, Rutz S, Crellin NK, et al. Regulation and functions of the IL-10 family of cytokines in inflammation and disease[J]. Annu Rev Immunol, 2011, 29:71-109. doi: 10.1146/annurev-immunol-031210-101312. [9] Sonnenberg GF, Fouser LA, Artis D. Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22[J]. Nat Immunol, 2011, 12(5):383-390. [10] Zenewicz LA, Flavell RA. Recent advances in IL-22 biology[J]. Int Immunol, 2011, 23(3):159-163. [11] Wolk K, Kunz S, Witte E, et al. IL-22 increases the innate immunity of tissues[J]. Immunity, 2004, 21(2):241-254. [12] Gurney AL. IL-22, a Th1 cytokine that targets the pancreas and select other peripheral tissues[J]. Int Immunopharmacol, 2004, 4(5):669-677. [13] Xie MH, Aggarwal S, Ho WH, et al. Interleukin (IL)-22, a novel human cytokine that signals through the interferon receptor-related proteins CRF2-4 and IL-22R[J]. J Biol Chem, 2000, 275(40):31335-31339. [14] Pickert G, Neufert C, Leppkes M, et al. STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing[J]. J Exp Med, 2009, 206(7):1465-1472. [15] Parikh A, Stephan AF, Tzanakakis ES. Regenerating proteins and their expression, regulation and signaling[J]. Biomol Concepts, 2012, 3(1):57-70. [16] Gironella M, Folch-Puy E, LeGoffic A, et al. Experimental acute pancreatitis in PAP/HIP knock-out mice[J]. Gut, 2007, 56(8):1091-1097. [17] Lin YY, Viterbo D, Mueller CM, et al. Small-interference RNA gene knockdown of pancreatitis-associated proteins in rat acute pancreatitis[J]. Pancreas, 2008, 36(4):402-410. [18] Czabotar PE, Lessene G, Strasser A, et al. Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy[J]. Nat Rev Mol Cell Biol, 2014, 15(1):49-63. [19] Sung KF, Odinokova IV, Mareninova OA, et al. Prosurvival Bcl-2 proteins stabilize pancreatic mitochondria and protect against necrosis in experimental pancreatitis[J]. Exp Cell Res, 2009, 315(11):1975-1989. [20] Xue J, Nguyen DT, Habtezion A. Aryl hydrocarbon receptor regulates pancreatic IL-22 production and protects mice from acute pancreatitis[J]. Gastroenterology, 2012, 143(6):1670-1680. [21] Zheng Y, Valdez PA, Danilenko DM, et al. Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens[J]. Nat Med, 2008, 14(3):282-289. [22] Radaeva S, Sun R, Pan HN, et al. Interleukin 22 (IL-22) plays a protective role in T cell-mediated murine hepatitis: IL-22 is a survival factor for hepatocytes via STAT3 activation[J]. Hepatology, 2004, 39(5):1332-1342. |
[1] | 董晓婧,李静,赵蕾,齐眉,孙泽雨,王红,赵蔚明. 鼠衣原体肺部感染中自然杀伤细胞对白细胞介素-22产生及疾病进程的影响[J]. 山东大学学报(医学版), 2016, 54(11): 19-23. |
[2] | 满琦,张安,张源,樊明德,马道新,王成伟. 脑胶质瘤患者外周血中Th17、Th22细胞的表达及意义[J]. 山东大学学报(医学版), 2016, 54(10): 55-59. |
[3] | 田馨莉, 矫俊, 张腾, 马道新, 崔保霞. Th22细胞联合Th17细胞在宫颈癌外周血中的表达及意义[J]. 山东大学学报(医学版), 2015, 53(7): 43-47. |
[4] | 张荣军, 韩波, 高聆, 朱梅, 丁国玉, 梁燕. siRNA沉默CD40基因对实验性自身免疫性心肌炎大鼠的作用及IL-22表达的影响[J]. 山东大学学报(医学版), 2015, 53(5): 36-40. |
[5] | 阮喜云1,魏敏2,毕建忠3,杨广笑4,王全颍4. hTRX-PR39重组腺相关病毒载体的构建[J]. 山东大学学报(医学版), 2011, 49(7): 61-64. |
[6] | 阮喜云1 ,毕建忠2 ,刘庆勇3 ,张士宝3 ,杨广笑4 ,王全颍4 . hTRXPR39融合基因cDNA克隆的构建及鉴定[J]. 山东大学学报(医学版), 2009, 47(03): 30-34. |
|